Search results
Results from the WOW.Com Content Network
The results are presented in two- and three-dimensional images called tractograms. [ 2 ] In addition to the long tracts that connect the brain to the rest of the body, there are complicated neural circuits formed by short connections among different cortical and subcortical regions.
The first MR images of a human brain were obtained in 1978 by two groups of researchers at EMI Laboratories led by Ian Robert Young and Hugh Clow. [1] In 1986, Charles L. Dumoulin and Howard R. Hart at General Electric developed MR angiography, [2] and Denis Le Bihan obtained the first images and later patented diffusion MRI. [3]
Structural magnetic resonance imaging (structural MRI) of a head, from top to base of the skull. The first chapter of the history of neuroimaging traces back to the Italian neuroscientist Angelo Mosso who invented the 'human circulation balance', which could non-invasively measure the redistribution of blood during emotional and intellectual activity.
The most significant impact of magnetic resonance neurography is on the evaluation of the large proximal nerve elements such as the brachial plexus (the nerves between the cervical spine and the underarm that innervate shoulder, arm and hand), [9] the lumbosacral plexus (nerves between the lumbosacral spine and legs), the sciatic nerve in the pelvis, [10] as well as other nerves such as the ...
Diffuse axonal injury (DAI) is a brain injury in which scattered lesions occur over a widespread area in white matter tracts as well as grey matter. [1] [2] [3] [4 ...
Anders Martin Dale is a prominent neuroscientist and professor of radiology, neurosciences, psychiatry, and cognitive science at the University of California, San Diego (UCSD), [1] and is one of the world's leading developers of sophisticated computational neuroimaging techniques.
In clinical practice, post-test probabilities are often just estimated or even guessed. This is usually acceptable in the finding of a pathognomonic sign or symptom, in which case it is almost certain that the target condition is present; or in the absence of finding a sine qua non sign or symptom, in which case it is almost certain that the target condition is absent.
The results of the analyser identify the type of vision defect. Therefore, it provides information regarding the location of any disease processes or lesion(s) throughout the visual pathway . This guides and contributes to the diagnosis of the condition affecting the patient's vision.